Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet

Clinical Trial To Evaluate ANT-1207 In Subjects With Lateral Canthal Lines

The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.

Inclusion Criteria:

• mild to moderate Crow's Feet wrinkles (IGA 2-3) at rest
• moderate to severe Crow's Feet (IGA 3-4) on contraction
• willingness to refrain from any product affecting skin remodeling
• female subjects must be not pregnant and non-lactating

Exclusion Criteria:

• history of peri-ocular surgery, brow lift or related procedures
• procedures affecting the lateral canthal region in the prior 12 months
• application of topical prescription medication to the treatment area
• female subjects who are pregnant or are nursing a child